Clinical Study: Vaginal Tissue Regeneration

Clinically Proven Effectiveness of Our Hyaluronic Acid-Based Vaginal Medical Device for Women’s Intimate Health Gruppo FarmaImpresa is proud to share the results of its clinical study, conducted on the medical device Revaginal Ovules. The study evaluated the safety and effectiveness of our vaginal ovules in promoting vaginal and uterine tissue regeneration, offering an innovative and…

GFI certifies a new Medical Device in Macedonia

Treatment for Vulvovaginal Mycotic Infections: FarmaImpresa Group certifies a new Medical Device in Macedonia We have completed the registration with the competent authorities in Macedonia for a Class I medical device, designed for the treatment of vulvovaginal mycotic infections. The medical device is formulated as a vaginal suppository based on hyaluronic acid, boric acid, and…